Social Media

Suzannah Palinkas's picture

Corporate Social Responsibility (Not That Kind)

0 comments

According to Wikipedia, Corporate Social [[wysiwyg_imageupload:112:]]
Responsibility (CSR) is described as “embracing responsibility and encouraging a positive impact through a company’s activities on the environment, consumers, employees, communities, stakeholders and all other members of the public sphere.” Perhaps we should reconsider this description and think of those words as they relate to Pharma in the online/social media space.

During a recent conference on the social/digital space, there were many examples of how Pharma can engage online. But, even with the positive examples given at the conference, our day-to-day experience can paint a different picture. Stung by warnings and violation letters, the Pharma world is very cautious of talking about their company, let alone a product, in the social media space. Read full post »

Tim Weinheimer's picture

Is Your Web Domain in Order for Responding to Unsolicited Requests?

0 comments

The process of prescribing, dispensing and using [[wysiwyg_imageupload:111:]]
medications leaves little room for medical errors when the health of the consumer is at stake.

The same holds true in making sure there is no room for error in “dispensing” prescription drug and medical device information on your web sites. The new FDA guidelines present the opportunity to ensure your customers can and will find readily accessible and accurate off-label information across your company and branded web properties. With the new FDA guidance for responding to unsolicited requests for off-label information, it may be time for a cross-domain audit of your web properties – an audit to simply ensure such off-label information is current and meeting FDA requirements.

Per the FDA recommendations, a firm’s contact and disclosure information, a public response should include a mechanism for providing readily accessible current FDA-required labelling, if any, for the product (e.g., FDA-approved package insert and, if the response is for a consumer, FDA-approved patient labelling or, for new animal drugs, FDA-approved client information sheet. Read full post »

In: Digital & Social Media  /   filed under: FDA | Social Media | website
Suzannah Palinkas's picture

What the Pirate Code Can Teach Us about Social Media in Pharma

0 comments

Recently, Suzannah Palinkas, Vice President, [[wysiwyg_imageupload:102:]]

Healthcare, Washington , D.C., attended the ExL Pharma 5th Annual Digital Pharma East conference in Philadelphia, PA. The following is the first installment in a series of posts inspired by insights gathered at the conference. 

“The pirate code is more what you'd call ‘guidelines’ than actual rules.”

– Captain Barbossa, Pirates of the Caribbean

  Read full post »

Emily Ng's picture

Preparing for the Plunge: Pharmaceuticals and Social Media

0 comments

 

In order to learn more about how social media can be impleme[[wysiwyg_imageupload:88:]]nted
in campaigns for our pharmaceutical clients,
I was recently fortunate enough to attend the Healthcare & Life Sciences Social Communications Leadership Forum in San Diego, CA. Held by PR Newswire in cooperation with the Business Development Institute, the forum comprised a group of marketing and communications professionals from a variety of medical-based companies who got together to discuss the important of social media within the healthcare industry. Read full post »

In: Digital & Social Media  /   filed under: pharma | physicians | Social Media
Amy Losak's picture

As Facebook Opens Up, What Will Pharma Do?

2 comments

Will “opening the walls” on Facebook, allowing people to post [[wysiwyg_imageupload:83:]]
public comments, lead to pharma companies shutting down their pages and abandoning this form of engagement with consumers?  Apparently, it already has, according to a recent Christian Torres’ article in the Washington Post. Read full post »

In: Digital & Social Media  /   filed under: facebook | FDA | pharma | Social Media